Mundipharma
Roger Miller is an experienced project management professional with a robust background in overseeing high-risk enterprise projects and software release planning. Currently serving as the Head of Project Services and Programme Manager at Mundipharma IT Services since July 2018, Roger previously held the position of Operations Manager at Cultura Technologies, where responsibilities included managing budget forecasting and operational expenses. Prior experience includes significant roles at K3 Syspro Limited as both a Programme/Account Manager and Head of Projects, supervising multi-year ERP programs and enhancing project governance. Roger’s career began as a Senior Consultant at EOH and included further consultancy roles at Information Engineering Group, all supported by an educational foundation from Cape Peninsula University of Technology.
This person is not in any teams
This person is not in any offices
Mundipharma
5 followers
The Mundipharma global network of independent associated companies shares a common purpose to identify and accelerate the development of meaningful medicines that add value for patients and healthcare providers around the globe. Founded in the US by two physicians in 1952 and still privately owned, the network has a presence in over 120 countries. In Europe, the network employees more than 2,000 employees from R&D to manufacturing & supply and commercial, and with revenues in excess of €1 billion. At Mundipharma we strive for one high performing and learning environment where individuals can make a real difference. We have a strong track record of building successful alliances to license, develop and market medicines that improve patients’ lives, while also providing attractive options to financially constrained healthcare systems. Consistent with our entrepreneurial heritage, we like to think that we see what others don’t by challenging conventional wisdom and asking different and challenging questions. By working in partnership with all our stakeholders, the Mundipharma network develops medicines that create value for patients, payers and wider healthcare systems. We have built a European portfolio of medicines to create value for patients, payers and wider healthcare systems across important therapeutic areas such as diabetes, respiratory, oncology, pain and biosimilars.